IL6 and metabolic dysfunction-associated steatotic liver disease: Ye et al.279 found that the lncRNA Gm9795 accelerates the pathogenesis of NAFLD by stimulating the expression of inflammatory mediators in NASH, including TNF, IL-6, and IL-1, instead of increasing fat accumulation.